Next Quarterly Earnings
Thursday, October 29, 2026
Expected
Apellis Pharmaceuticals
Apellis Pharmaceuticals is a US-based biotechnology company dedicated to developing innovative therapies for complement-driven diseases. The company's focus is on researching and advancing treatments for rare diseases such as PNH and severe eye conditions, including geographic atrophy, aiming to provide patients with new perspectives and hope for improved outcomes.
Frequently asked questions
When did Apellis Pharmaceuticals last report quarterly earnings?
Apellis Pharmaceuticals last reported quarterly earnings on 10/30/2025 (Q3 2025).
How often has Apellis Pharmaceuticals beaten expectations?
Apellis Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 4 evaluated quarters (beat rate: 75%).
How do I add the Apellis Pharmaceuticals earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
3/4
Quarters above estimates
75%
Beat rate
+0.6%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Apellis Pharmaceuticals
Country
🇺🇸
More Financial Information